MedWatch

Results: 721



#Item
101Report to Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce Report on Study Commitment Regarding Inclusion of Toll-Free Adverse Event Reporting Number by FDA

Report to Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce Report on Study Commitment Regarding Inclusion of Toll-Free Adverse Event Reporting Number by FDA

Add to Reading List

Source URL: www.fda.gov

Language: English
102FDA Patient Safety News: Show #46, December 2005

FDA Patient Safety News: Show #46, December 2005

Add to Reading List

Source URL: www.fda.gov

Language: English
103FDA Patient Safety News: Show #42, August 2005

FDA Patient Safety News: Show #42, August 2005

Add to Reading List

Source URL: www.fda.gov

Language: English
104FDA Patient Safety News: Show #26, April 2004

FDA Patient Safety News: Show #26, April 2004

Add to Reading List

Source URL: www.fda.gov

Language: English
105FDA-3500A_Instructions_generate pdf_combine with 3-pg vsn.indd

FDA-3500A_Instructions_generate pdf_combine with 3-pg vsn.indd

Add to Reading List

Source URL: www.fda.gov

Language: English
106FDA Patient Safety News: Show #93, December 2009

FDA Patient Safety News: Show #93, December 2009

Add to Reading List

Source URL: www.fda.gov

Language: English
107TANZEUM (Albiglutide) Glucagon-like Peptide-1 (GLP-1) Receptor Agonist,

TANZEUM (Albiglutide) Glucagon-like Peptide-1 (GLP-1) Receptor Agonist,

Add to Reading List

Source URL: www.fda.gov

Language: English
108FDA Patient Safety News: Show #89, August 2009

FDA Patient Safety News: Show #89, August 2009

Add to Reading List

Source URL: www.fda.gov

Language: English
109FDA Patient Safety News: Show #70, December 2007

FDA Patient Safety News: Show #70, December 2007

Add to Reading List

Source URL: www.fda.gov

Language: English
110FDA Patient Safety News: Show #106, January 2011

FDA Patient Safety News: Show #106, January 2011

Add to Reading List

Source URL: www.fda.gov

Language: English